Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997

Daniel R. Feikin, Anne Schuchat, Margarette Kolczak, Nancy L. Barrett, Lee H. Harrison, Lewis Lefkowitz, Allison McGeer, Monica M. Farley, Duc J. Vugia, Catherine Lexau, Karen R. Stefonek, Jan E Patterson, James H. Jorgensen

Research output: Contribution to journalArticle

495 Citations (Scopus)

Abstract

Objectives. This study examined epidemiologic factors affecting mortality from pneumococcal pneumonia in 1995 through 1997. Methods. Persons: residing in a surveillance area who had community-acquired pneumonia requiring hospitalization and Streptococcus pneumoniae isolated from a sterile site were included in the analysis. Factors affecting mortality were evaluated in univariate and multivariate analyses. The number of deaths from pneumococcal pneumonia requiring hospitalization in the United States in 1996 was estimated. Results. Of 5837-cases, 12% were fatal. Increased mortality was associated with older age, underlying disease, Asian race, and residence in Toronto/Peel, Ontario. When these factors were controlled for, increased mortality was not associated with resistance to penicillin i or cefotaxime. However, when deaths during the first 4 hospital days were excluded, mortality was significantly associated with penicillin minimum inhibitory concentrations of 4.0 or higher and cefotaxime minimum inhibitory concentrations of 2.0 or higher. In 1996, about 7000 to 12500 deaths occurred in the United States from pneumococcal pneumonia requiring hospitalization. Conclusions. Older age and underlying disease remain the most important factors influencing death from pneumococcal pneumonia. Mortality was not elevated in most infections with β-actam-resistant pneumococci.

Original languageEnglish (US)
Pages (from-to)223-229
Number of pages7
JournalAmerican Journal of Public Health
Volume90
Issue number2
StatePublished - Feb 2000

Fingerprint

Pneumococcal Pneumonia
Microbial Drug Resistance
Mortality
Hospitalization
Cefotaxime
Microbial Sensitivity Tests
Streptococcus pneumoniae
Epidemiologic Factors
Penicillin Resistance
Ontario
Penicillins
Pneumonia
Multivariate Analysis
Infection

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Feikin, D. R., Schuchat, A., Kolczak, M., Barrett, N. L., Harrison, L. H., Lefkowitz, L., ... Jorgensen, J. H. (2000). Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. American Journal of Public Health, 90(2), 223-229.

Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. / Feikin, Daniel R.; Schuchat, Anne; Kolczak, Margarette; Barrett, Nancy L.; Harrison, Lee H.; Lefkowitz, Lewis; McGeer, Allison; Farley, Monica M.; Vugia, Duc J.; Lexau, Catherine; Stefonek, Karen R.; Patterson, Jan E; Jorgensen, James H.

In: American Journal of Public Health, Vol. 90, No. 2, 02.2000, p. 223-229.

Research output: Contribution to journalArticle

Feikin, DR, Schuchat, A, Kolczak, M, Barrett, NL, Harrison, LH, Lefkowitz, L, McGeer, A, Farley, MM, Vugia, DJ, Lexau, C, Stefonek, KR, Patterson, JE & Jorgensen, JH 2000, 'Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997', American Journal of Public Health, vol. 90, no. 2, pp. 223-229.
Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. American Journal of Public Health. 2000 Feb;90(2):223-229.
Feikin, Daniel R. ; Schuchat, Anne ; Kolczak, Margarette ; Barrett, Nancy L. ; Harrison, Lee H. ; Lefkowitz, Lewis ; McGeer, Allison ; Farley, Monica M. ; Vugia, Duc J. ; Lexau, Catherine ; Stefonek, Karen R. ; Patterson, Jan E ; Jorgensen, James H. / Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. In: American Journal of Public Health. 2000 ; Vol. 90, No. 2. pp. 223-229.
@article{09492017cc4440868c8d6d90eae52442,
title = "Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997",
abstract = "Objectives. This study examined epidemiologic factors affecting mortality from pneumococcal pneumonia in 1995 through 1997. Methods. Persons: residing in a surveillance area who had community-acquired pneumonia requiring hospitalization and Streptococcus pneumoniae isolated from a sterile site were included in the analysis. Factors affecting mortality were evaluated in univariate and multivariate analyses. The number of deaths from pneumococcal pneumonia requiring hospitalization in the United States in 1996 was estimated. Results. Of 5837-cases, 12{\%} were fatal. Increased mortality was associated with older age, underlying disease, Asian race, and residence in Toronto/Peel, Ontario. When these factors were controlled for, increased mortality was not associated with resistance to penicillin i or cefotaxime. However, when deaths during the first 4 hospital days were excluded, mortality was significantly associated with penicillin minimum inhibitory concentrations of 4.0 or higher and cefotaxime minimum inhibitory concentrations of 2.0 or higher. In 1996, about 7000 to 12500 deaths occurred in the United States from pneumococcal pneumonia requiring hospitalization. Conclusions. Older age and underlying disease remain the most important factors influencing death from pneumococcal pneumonia. Mortality was not elevated in most infections with β-actam-resistant pneumococci.",
author = "Feikin, {Daniel R.} and Anne Schuchat and Margarette Kolczak and Barrett, {Nancy L.} and Harrison, {Lee H.} and Lewis Lefkowitz and Allison McGeer and Farley, {Monica M.} and Vugia, {Duc J.} and Catherine Lexau and Stefonek, {Karen R.} and Patterson, {Jan E} and Jorgensen, {James H.}",
year = "2000",
month = "2",
language = "English (US)",
volume = "90",
pages = "223--229",
journal = "American Journal of Public Health",
issn = "0090-0036",
publisher = "American Public Health Association Inc.",
number = "2",

}

TY - JOUR

T1 - Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997

AU - Feikin, Daniel R.

AU - Schuchat, Anne

AU - Kolczak, Margarette

AU - Barrett, Nancy L.

AU - Harrison, Lee H.

AU - Lefkowitz, Lewis

AU - McGeer, Allison

AU - Farley, Monica M.

AU - Vugia, Duc J.

AU - Lexau, Catherine

AU - Stefonek, Karen R.

AU - Patterson, Jan E

AU - Jorgensen, James H.

PY - 2000/2

Y1 - 2000/2

N2 - Objectives. This study examined epidemiologic factors affecting mortality from pneumococcal pneumonia in 1995 through 1997. Methods. Persons: residing in a surveillance area who had community-acquired pneumonia requiring hospitalization and Streptococcus pneumoniae isolated from a sterile site were included in the analysis. Factors affecting mortality were evaluated in univariate and multivariate analyses. The number of deaths from pneumococcal pneumonia requiring hospitalization in the United States in 1996 was estimated. Results. Of 5837-cases, 12% were fatal. Increased mortality was associated with older age, underlying disease, Asian race, and residence in Toronto/Peel, Ontario. When these factors were controlled for, increased mortality was not associated with resistance to penicillin i or cefotaxime. However, when deaths during the first 4 hospital days were excluded, mortality was significantly associated with penicillin minimum inhibitory concentrations of 4.0 or higher and cefotaxime minimum inhibitory concentrations of 2.0 or higher. In 1996, about 7000 to 12500 deaths occurred in the United States from pneumococcal pneumonia requiring hospitalization. Conclusions. Older age and underlying disease remain the most important factors influencing death from pneumococcal pneumonia. Mortality was not elevated in most infections with β-actam-resistant pneumococci.

AB - Objectives. This study examined epidemiologic factors affecting mortality from pneumococcal pneumonia in 1995 through 1997. Methods. Persons: residing in a surveillance area who had community-acquired pneumonia requiring hospitalization and Streptococcus pneumoniae isolated from a sterile site were included in the analysis. Factors affecting mortality were evaluated in univariate and multivariate analyses. The number of deaths from pneumococcal pneumonia requiring hospitalization in the United States in 1996 was estimated. Results. Of 5837-cases, 12% were fatal. Increased mortality was associated with older age, underlying disease, Asian race, and residence in Toronto/Peel, Ontario. When these factors were controlled for, increased mortality was not associated with resistance to penicillin i or cefotaxime. However, when deaths during the first 4 hospital days were excluded, mortality was significantly associated with penicillin minimum inhibitory concentrations of 4.0 or higher and cefotaxime minimum inhibitory concentrations of 2.0 or higher. In 1996, about 7000 to 12500 deaths occurred in the United States from pneumococcal pneumonia requiring hospitalization. Conclusions. Older age and underlying disease remain the most important factors influencing death from pneumococcal pneumonia. Mortality was not elevated in most infections with β-actam-resistant pneumococci.

UR - http://www.scopus.com/inward/record.url?scp=0033959389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033959389&partnerID=8YFLogxK

M3 - Article

C2 - 10667183

AN - SCOPUS:0033959389

VL - 90

SP - 223

EP - 229

JO - American Journal of Public Health

JF - American Journal of Public Health

SN - 0090-0036

IS - 2

ER -